Comprehensive analysis of human IL-4 receptor subunits shows compartmentalization in steady state and dupilumab treatment.

Collectively, our findings suggest that distinct human immune cell subsets contain surface and intracellular IL-4R pools, which are differently affected by targeted biologic treatment.